Background: Rasmussen's encephalitis (RE) is an inflammatory encephalopathy of unknown cause defined by seizures with progressive neurological disabilities. Herein, the pathogenesis of RE was investigated focusing on inflammasome activation in the brain. Methods: Patients with RE at the University of Alberta, Edmonton, AB, Canada, were identified and analyzed by neuroimaging, neuropsychological, molecular, and pathological tools. Primary human microglia, astrocytes, and neurons were examined using RT-PCR, enzyme-linked immunosorbent assay (ELISA), and western blotting.
Background
Rasmussen's encephalitis (RE) is a rare progressive encephalopathy defined by chronic focal epilepsy, neurocognitive, and motor deficits with neuroinflammation [1, 2] . Clinical features of RE include intractable seizures, hemiparesis, blindness, and neurocognitive dysfunction [3] . The major seizure semiology associated with RE is epilepsia partialis continua, which is difficult to control with current antiepileptic drugs [4] . RE is chiefly a disease of children but occasionally occurs in adulthood (10%) and can be fatal depending on the severity of the disease. Treatment options for RE are limited to controlling the seizures with antiepileptic drugs together with radical neurosurgical interventions (corticectomy or hemispherectomy) associated with major postoperative neurologic deficits including hemiparesis and hemianopsia [5] . Therapeutic immunomodulation and/or immunoablation in RE as well as antiviral therapies have been reported with inconclusive results [6, 7] .
Although there is substantial clinical heterogeneity, RE usually displays neuropathological features consisting of inflammation, gliosis, and tissue destruction in the cortex of the affected hemisphere, often with relative sparing of the basal ganglia, contralateral hemisphere, and posterior fossa structures. The observed inflammatory changes in RE include perivascular cuffing, microglial nodules, T lymphocytic infiltration gliosis, meningeal inflammation, and neuronal injury or loss [2, 8] . The underlying etiology of RE is unknown; several exogenous pathogens have been postulated as causative [9] but autoimmune mechanisms have also been reported, largely based on the infiltration of T lymphocytes (CD8+) and macrophages at the disease onset accompanied by gliosis and neurodegeneration in the cerebral cortex [10] .
Inflammation in the nervous system occurs in multiple neurological disorders with diverse causes and pathological phenotypes. Recently, the contribution of innate immunity to neurological disease has garnered increased attention, especially with the recognition of inflammasome activation [11] . Inflammasomes represent complex protein aggregates formed by cytosolic receptors, their adaptor proteins, and caspase-1, which regulate the maturation and release of IL-1β and IL-18 [12] . Activation of an inflammasome involves an orchestrated engagement of cell signaling molecules that primes cells to express pro-IL-1β (signal 1) with subsequent signals that trigger the formation of an inflammasome complex (signal 2). The formation of these complexes mediates the cleavage and release of active IL-1β, which participates in the development and promulgation of inflammatory responses. Inflammasome activation has recently been implicated in bacterial meningitis, autoimmune demyelination, and chronic neurodegenerative disease [13] [14] [15] . Nonetheless, little is known about inflammasome expression and function in human neural cells.
Given the disabling nature of the motor features associated with RE together with previous imaging and neuropathological studies suggesting white matter involvement, we hypothesized that the disease process extended beyond the cortex into the proximal white matter in RE and might engage inflammasome cellular components because of RE's inflammatory features. In fact, the present studies revealed that among RE patients there was converging evidence of white matter pathogenesis, based on neuropsychological, neuroimaging, molecular, and neuropathological analyses. Moreover, induction of multiple components implicated in inflammasome expression was evident in both cortex and white matter of RE patients, particularly in activated myeloid cells.
Methods and materials

Clinical studies
A retrospective review of all patients diagnosed with RE in the Comprehensive Epilepsy Program was performed based on the published criteria for RE [4] , using the demographic, clinical, laboratory, neuroimaging, and treatment data of patients followed in this program, with University of Alberta (Edmonton, AB, Canada) Ethics Committee approval. To confirm, corroborate, and establish the diagnosis of RE, all patients referred to the program with epilepsy and an abnormal cranial magnetic resonance imaging (MRI) were evaluated by a pediatric epileptologist (DBS, RTW). The patients presented herein (n = 4; ages 3 to 14 years) represent all identified cases of RE during the years from 1999 to 2009 (Table 1) . Patient control brain specimens (mean age 19.4 ± 12.9 years; males, n = 4; mesial temporal sclerosis (n = 5), multiple sclerosis (n = 1)) for the molecular studies included both cortex and white matter.
Neuropsychological studies
Neuropsychological assessments were conducted for clinical purposes of treatment and educational planning. . Serial neuropsychological examinations were performed at presentation and at subsequent time points (1 year after initial assessment for patients 2 and 4; 2 years after initial assessment for patient 3) as part of routine evaluation prior to surgery [16] .
Tissue samples
Frozen brain tissue (cortex and white matter) was collected from RE patients (n = 3, tissue was not available from patient 4) and control subjects undergoing cerebral resections for epilepsy (non-RE; n = 5; mean age 19 ± 10 years) for molecular and neuropathological studies, as described previously [17] . These studies were approved by the University of Alberta Ethics Committee (Pro00002291).
Neuropathological studies
All patients underwent hemispherectomy or cortical resection and all tissues were reviewed at gross assessment and after histological and immunocytochemical staining by a certified neuropathologist (EJ) [17] . Next, 10 μM paraffin-embedded sections of human brain tissue from RE and non-RE were deparaffinized and hydrated using decreasing concentrations of ethanol. Sections were boiled in 0.01 M citrate buffer, pH 6.0, for 10 minutes prior to application of antibodies that detected CD3, CD8, CD68, vimentin, IL-1β, caspase-1, major histocompatibility complex (MHC) class II, and alanine/serine/ cysteine (ASC); antibodies included anti-ASC (AL177, Adipogen, San Diego, CA, USA), anti-IL-1β and anticaspase-1 (sc-7884 and sc-515, respectively, Santa Cruz Biotechnology, Dallas, TX, USA), anti-MHC class II (M0775, Dako, Glostrup, Denmark), anti-IL18 (D043-3, MBL International, Woburn, MA, USA), anti-CD3 (790-4341, Ventana, Tuscon, AZ, USA), anti-CD8 (M7103, Dako), anti-CD68 (M0814, Dako), and anti-vimentin (M0725, Dako). Primary antibodies were diluted in PBS/ serum and incubated overnight at room temperature. Immunolabeling with primary antibodies was detected with biotinylated goat-anti-rabbit or biotinylated goatanti-mouse (Vector Laboratories, Burlingame, CA, USA) and avidin-biotin-peroxidase complex (ABC, Vector Laboratories). Sections were counter-stained with hematoxylin.
Human neural cell cultures
Human fetal astrocytes (HFAs), microglia, and neurons were prepared from 15-to 19-week fetal brains obtained, with consent (approved by the University of Alberta Ethics Committee, Pro00027660), as previously described [17] [18] [19] [20] [21] . Briefly, fetal brain tissues were dissected, meninges were removed and digested for 30 minutes with 2.5% trypsin (Life Technologies, Burlington, ON, Canada) and 2 mg/mL DNase I (Roche Diagnostics, Mannheim, Germany), and passaged through a 70 μm cell strainer (BD Biosciences, Mississauga, ON, Canada). Cells were washed twice with centrifugation at 14,000 rpm for 10 minutes and plated in T-75 flasks coated with poly-L-ornithine (Sigma-Aldrich, Oakville, ON, Canada) at 6 to 8 × 10 7 cells/flask with media. Following a week of incubation (37°C at 5% CO 2 ), adherent HFAs were separated from suspended microglia and re-plated for primary astrocytic, neuronal, or microglia differentiation (80% confluence). Cells were maintained in MEM containing 10% FBS (Life Technologies), 1% penicillin/streptomycin (Life Technologies), 1% L-glutamine (Life Technologies), and 10% dextrose (Life Technologies).
Real-time RT-PCR
Tissues were homogenized and then lysed in TRIzol (Invitrogen, Carlsbad, CA, USA) and used in real-time PCR analyses as previously described. Briefly, human cerebral samples (white matter and adjacent cortex) and cultured cells were homogenized in TRIzol and total RNA was purified from the aqueous phase using RNeasy mini columns (Qiagen, Valencia, CA, USA) [16] . Following digestion of RNA with DNase I (Promega, Madison, WI, USA), cDNA was prepared by oligo(dT) primed reverse transcription of equal quantities of RNA using either SuperScript II or SuperScript III Reverse Transcriptase (Invitrogen) according to the manufacturer's recommended protocols. Semi-quantitative real-time RT-PCR was performed using iQ SYBR Green supermix (Bio-Rad Laboratories, Hercules, CA, USA) on either an iQ5 or iCycler (Bio-Rad Laboratories) according to the manufacturer's recommended protocols. Oligonucleotide PCR primers are provided in Table 2 . All data were normalized to GAPDH mRNA levels and expressed as relative fold changes (RFCs) compared to non-RE controls.
In vitro activation and protein expression
To stimulate protein expression or release from primary microglia or astrocytes, cells isolated as described above were seeded at a density of 7 × 10 5 cells/well and treated for 18 hours with either TNFα (50 ng/mL) or LPS (25 ng/mL). Following LPS priming, cells were treated for 2 hours with either ATP (500 μM) or MDP (500 ng/mL) for 6 hours to further trigger formation of inflammasome complexes. The caspase inhibitor, zVAD-fmk (100 μM), was used to inhibit these responses. Cell lysates from treated cells were collected in standard Laemmli sample loading buffer run on 12% gels and analyzed by western blot. The same antibodies used for immunohistochemistry were used for western blotting (see above). Alternatively, to measure release of IL-1β from stimulated cells, cell culture supernatants were collected and analyzed by enzyme-linked immunosorbent assay (ELISA; DY201, R&D Systems, Minneapolis, MN, USA).
Statistical analyses
For determination of differences in neuropsychological performance and transcript levels, Mann-Whitney U or Student's t-tests were performed using GraphPad Prism version 5 for OS X (GraphPad Software, San Diego, CA USA; www.graphpad.com). P values <0.05 were considered significant.
Results
Clinical and demographic features
Herein, four individuals were identified with clinical, imaging, and pathological features of RE, ranging in age from 3 to 14 years at the time of presentation (three females, one male), exhibiting different seizure types and outcomes (Table 1) , and all of whom underwent surgery for removal of the epileptogenic regions. All patients exhibited neuropathological features characteristic of RE including astrogliosis, leukocyte infiltration, and neuronal injury.
Neuroimaging and neuropsychological studies
Serial cranial MRI demonstrated increased signal apparent in both the cortex and adjacent matter in the affected (left) hemisphere (T2-weighted) for patient 2 ( Figure 1A ) with minimal gadolinium enhancement (data not shown). Similarly, patient 3 also exhibited increased signal in both cortex and white matter, which progressed over time and remained apparent after a partial resection of the lesion. Patients 1 and 4 demonstrated normal neuroimaging at presentation but developed significant atrophy of cortex and white matter of the left hemisphere within months of presentation (data not shown). Among patients 2, 3, and 4, longitudinal neuropsychological analyses were performed prior to surgery using established tests of language, attention, memory, motor functions, and processing speed. Median T scores (n = 3, patients 2 to 4) declined significantly between first and last assessments for processing speed, while memory (verbal and nonverbal), language, dominant motor, and non-dominant motor performances remained unchanged over time ( Figure 1B ). As expected with left hemispheric lesions, language function was reduced in all three patients at both early and late time points. Reliable neuropsychological assessment could not be performed in patient 1 due to the early age at presentation. The reduction in processing speed efficiency herein implied that subcortical structures might be affected, prompting examination of both cortex and adjacent white matter with molecular and morphological tools.
Host neuroimmune responses
Earlier studies indicate that leukocyte infiltration was a key aspect of the neuropathogenesis of RE [22, 23] , perhaps in response to expression of host autoantigens or infectious agents. Comparison of cortex and white matter transcript Forward 5′-GCC TGC ACT TTA TAG ACC AGC-3′   Reverse 5′-GCT TCC GCA TCT TGC TTG G- levels revealed that HLA-DR and CD3ε transcript levels were significantly increased in both cortex and adjacent white matter of RE patients (patients 1, 2, 3) compared to matched regions from non-RE patients (Figure 2A ; Additional file 1). In addition, TNF-α transcript levels were induced in the white matter of RE patients compared to non-RE patients as well as matched cortical samples, while GFAP transcript levels were non-significantly increased in the white matter of RE patients (Figure 2A) . Given the extent of neuroinflammation in the brain specimens of RE patients, particularly in white matter, the molecular machinery involved in inflammasome activation was investigated revealing that IL-1β transcript levels were increased in the white matter of RE patients compared to white matter from non-RE patients and matched RE cortical specimens ( Figure 2B ). Further analyses disclosed that NLRP1 and NLRP3 transcript levels were increased in RE white matter and cortex, while casp1 and IL-18 transcript levels were also significantly increased in both white matter and cortex of RE patients. ASC mRNA expression was selectively increased (by >80 fold) in white matter of RE patients ( Figure 2B ). These observations pointed to substantial increases in expression of genes implicated in inflammasome induction and function.
Neural cell expression of inflammasome components
The above studies highlighted a role for inflammasome activation in RE but the cell type(s) contributing to increased inflammasome expression in the human nervous system remain uncertain. Analyses of mRNA from cultured primary human microglia, astrocytes, and neurons showed that casp1, NLRP1, NLRP3, NLRC4, and ASC transcripts were consistently detectable in human microglia ( Figure 3A) . In contrast, NLRP1 transcripts were expressed at low levels in human astrocytes, while the remaining genes were minimally detected in astrocytes and neurons. Thus, subsequent studies focused on primary human microglia. In order to examine expression of inflammasome components and substrates within microglia prior to inflammasome activation, lysates from untreated cells or cells stimulated with TNF-α were examined by western blot. Exposure of microglia to TNF-α induced pro-IL-1β immunoreactivity in cell lysates without altering the constitutive expression of IL-18, ASC, or caspase-1 ( Figure 3B ). To explore the induction of IL-1β in more depth, human microglia were primed with endotoxin (LPS) as a 'signal 1' followed by exposure to established activators of inflammasomes including ATP or MDP ('signal 2'), revealing that under these conditions LPS alone not only induced expression of pro-IL-1β but also triggered its cleavage, yielding the mature form (IL-1β p17). However, this cleavage event was accentuated by exposure to the signal 2 molecules ( Figure 3C ). Treatment of stimulated microglia with the general caspase inhibitor, zVAD-fmk, eliminated the occurrence of mature IL-1β ( Figure 3C ). To investigate the release of IL-1β from stimulated glial cells, supernatants from LPS primed human microglia and astrocytes exposed to ATP or MDP showed detectable IL-1β in supernatants from microglia but without IL-1β release from astrocytes. These studies suggested the inflammasome components were principally located in microglia and that cultured human microglia could produce IL-1β with exposure to T score L a n g u a g e only a signal 1 but addition of a signal 2 enhanced the expression and release of IL-1β.
Neuropathological studies
Given the above clinical, imaging, neuropsychological, and molecular findings, we next examined the neuropathological features of RE. Analyses of white matter from non-RE and RE patients, disclosed CD3ε-immunopositive cells were highly abundant in perivascular spaces and parenchyma in RE brain sections ( Figure 4B ) compared to non-RE white matter ( Figure 4A ). CD8 immunopositive cells were infrequently observed in the non-RE white matter ( Figure 4C ) but were readily detected in RE white matter ( Figure 4D ). Occasional CD68+ perivascular myeloid cells were found in the non-RE white matter ( Figure 4E ), while numerous hypertrophied CD68+ cells resembling microglia and macrophages were evident in RE white matter including microglial nodules ( Figure 4F ). Vimentin immunoreactivity was apparent in endothelial cells in non-RE brains ( Figure 4G ) but was markedly increased in RE white matter in both endothelia and astrocytes ( Figure 4H ). Similar neuropathological changes were observed in the adjacent cortex from RE patients: immunolabeling disclosed minimal CD3ε (Additional file 2: Figure S2A ), CD8 (Additional file 2: Figure S2B ), and CD68 (Additional file 2: Figure S1C ) in non-RE cortex compared with RE cortical sections (Additional file 2: Figure S2D ,E,F). Thus, inflammation involving activated myeloid, lymphoid, and astrocytic cells was evident in both white matter and cortex in RE sections.
Inflammasome expression in RE
To extend the findings of increased transcript expression of inflammasome-associated genes in the brains from RE patients (Figure 1) , MHC class II immunoreactivity was investigated showing markedly increased expression in the white matter of RE brain tissues ( Figure 4J ) compared to non-RE patients ( Figure 4I ) with similar changes in the adjacent cortex (Additional file 3: Figure S3A ). IL-1β immunoreactivity was not detected in white matter from non-RE patients ( Figure 4K ) but was apparent in RE white matter, localized in cells resembling microglia ( Figure 4L ), which was verified by co-localization with MHC class II immunoreactivity ( Figure 4L, inset) . IL-1β immunoreactivity was also detected in the microglial-like cells in RE cortex (Additional file 3: Figure  S3B ). Caspase-1 immunopositive cells, which also resembled microglia, were abundant in RE white matter ( Figure 4N ) in contrast to minimal detection in non-RE tissue ( Figure 4M ) with similar detection levels in RE cortex in microglia (Additional file 3: Figure S3D ). In white matter from RE patients, ASC immunostaining was frequently detected in cells with morphological appearance of activated myeloid cells ( Figure 4P ) but was minimally found in non-RE white matter ( Figure 4O ). However, ASC immunopositive cells were scarce in RE cortex (Additional file 3: Figure S3D ). These findings emphasized the induction of inflammasome components in RE brain tissues, particularly in white matter, in keeping with chronic inflammation and the associated neuroimaging and neuropsychological findings.
Discussion
The present study represents the first analysis of RE patients integrating neuroimaging, neuropsychological, neuropathological, and molecular findings, which revealed both white matter and cortex involvement in the RE disease process with a concurrent induction of inflammasome components. This report is also one of the first to examine inflammasome expression and activation in human neural cells (microglia, astrocytes, neurons), disclosing that microglia and macrophages are the chief cells demonstrating inflammasome cellular machinery. There was evidence of lymphocyte invasion of RE brain tissues, particularly CD8+ T cells, in keeping with previous RE studies [8, 22, 23] . These immune perturbations likely contribute to the pathogenesis of RE, perhaps indicating an ability to respond by activating an inflammasome complex. The present observations also highlight the broader extent of cerebral tissue disruption (cortex and white matter) in RE, which was evident in multiple investigative platforms. There has been a strong emphasis on the cerebral cortex as the principal target of tissue damage in RE, predicated largely on neuropathological studies showing gliosis and neuronal dysplasia and/or loss [22, 24] . However, limited attention has been focused on pathological changes in adjacent white matter in RE, although several earlier studies show apparent changes in white matter in both neuropathological and neuroimaging analyses [10, 22, 25] . This study integrating neuroimaging, neuropsychological assessments, and expression of neuroinflammatory markers is consistent with progressive cerebral white matter involvement. The present serial neuropsychological assessments reveal current (progressive) white matter pathogenesis in RE because processing speed is dependent on white matter integrity; this variable worsened in the present cohort over time. It is unclear if white matter compromise early in the course of disease is reversible. Importantly, the finding of impaired language function early in the course of disease and early white matter changes on neuroimaging might implicate either early white matter disconnection and/or cortical injury [26] . The etiology of RE is unknown although both infectious and autoimmune etiologies have been postulated. The worldwide identification of RE makes an infectious agent a less plausible etiology unless it is a ubiquitous agent infecting a selectively 'neurosusceptible' group [27] . An autoimmune pathogenesis remains a strong possibility, as the current study revealed a combination of significant lymphocyte infiltration and gliosis in white matter suggesting immune dysregulation. Relevant to this finding, a study of CD8+ T cells in RE reveals the persistence of cytotoxic T lymphocytes in close proximity to neurons and astrocytes, consistent with antigen-driven CD8+ T cells mediating attack on neurons and astrocytes [8, 23] . This current study shows for the first time that inflammasome activation is highest in human microglia and induction of the inflammasome results in selective release of IL-1b by microglia, but not astrocytes. This observation, coupled with our finding that genes involved in inflammasome activation are highest in the white matter of RE patients, along with the ubiquitous finding of microglial activation in RE supports a role for inflammasome activation in microglia in the pathogenesis of RE. Currently the role of the inflammasome in other central nervous system inflammatory disorders is unclear particularly in other white matter diseases such as multiple sclerosis, and warrants further investigation. Delineation of which inflammasome complex is activated in RE might lead to further insights into the etiopathogenesis of RE. Both NLRP1 and NLRP3 exhibited increased expression in RE brain specimens relative to controls with mesial temporal sclerosis and multiple sclerosis ( Figure 1 ). However, it is plausible that other inflammasomes might exhibit increased expression. Future studies will need to examine newer inflammasome components as they become better defined but the present studies highlight the enhanced expression of both NLRP1 and NLRP3 in brains from RE patients. Although this study is limited by small numbers due primarily to the rarity of this disease, these findings raise the possibility of targeting inflammasomes as part of future therapeutic strategies for RE. Several possible agents include glyburide, which modulates pannexin-1, and new drugs such as cytokine release inhibitory drug (CRID)3 and milk fat globule-EGF factor 8 protein (MFGE8) [28, 29] . neuropathological findings. FM and WB performed and analyzed immunohistochemical staining. DBS, RTW, BM, and DWG collected, analyzed, and interpreted results. CP supervised all aspects of the study. VR and CP wrote the manuscript. All authors read and approved the final version of the manuscript.
